Uzbekistan’s Genomics and Bioinformatics Center has bee working on creating an edible vaccine against COVID-19 based on tomatoes, according to its director Zabardast Buriev who shared the programme’s details on Friday.
The treatment is made by transferring the cloned S-protein of COVID-19 into a vegetable. It doesn’t require special conditions for storage and transportation as well as special equipment and a lot of personnel.
Scientists suggest that an edible vaccine could as well potentially cause fewer side effects. Preclinical trials are currently underway on mice.
After animal testing is completed, researchers plan to start human clinical trials, Buriev said. According to scientists’ preliminary data, the ‘vaccine’ effect will last for about a year and a half if COVID-19 doesn’t mutate further.